Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions
| Status: | Completed |
|---|---|
| Conditions: | Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 18 - 45 |
| Updated: | 1/25/2018 |
| Start Date: | August 2005 |
| End Date: | August 2005 |
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions
The objective of this study was to prove the bioequivalence of Levetiracetam 750 mg Tablets
under fed conditions
under fed conditions
Inclusion Criteria:
- No clinically significant abnormal findings on the physical examination, medical
history, or clinical laboratory results during screening
Exclusion Criteria:
- Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme
altering drugs. History of allergic or adverse response to Levetiracetam or any
comparable or similar product.
We found this trial at
1
site
Click here to add this to my saved trials
